Minerva Neurosciences | Capitalisation Boursière

Prix De L'Action
6.33
Variation Quotidienne
0.02 0.32%
Mensuellement
46.53%
Annuel
222.96%
Q1 Prévisions
2.46




Capitalisation Boursière Changement Date
Acadia Pharmaceuticals USD 3.6B 10M 2025-09
Adma Biologics USD 3.49B 853M 2025-09
ALKERMES USD 4.95B 235M 2025-09
Alterity Therapeutics Limited AUD 11M 5M 2023-06
AstraZeneca USD 222.33B 65.82B 2026-02
BioCryst Pharmaceuticals USD 1.23B 115M 2023-12
Bristol-Myers Squibb USD 123.58B 13.77B 2026-02
Cipla INR 1.22T 6.47B 2025-12
Clal Biotechnology ILS 47.99M 4.37M 2026-01
Compugen USD 137.5M 21.89M 2025-09
CSL USD 76.3B 60.04B 2025-06
Dynavax Technologies USD 1.16B 26M 2025-09
Eli Lilly USD 1.01T 3.37B 2026-02
Esperion Therapeutics USD 340M 235M 2023-12
GlaxoSmithKline GBP 87.33B 12.98B 2026-02
Grifols EUR 6.77B 773M 2025-09
Halozyme Therapeutics USD 8.58B 2.17B 2025-09
Ionis Pharmaceuticals USD 10.43B 4.14B 2025-09
J&J USD 500.24B 67.44B 2025-12
Merck USD 300.37B 39.11B 2026-02
Minerva Neurosciences USD 43M 5M 2023-12
Neurocrine Biosciences USD 13.7B 221M 2026-02
Novartis USD 265.66B 9.48B 2025-09
Novavax USD 684M 43M 2023-09
Pfizer USD 152.89B 11.32B 2026-02
Roche Holding CHF 266.34B 55.46B 2025-12
Sanofi EUR 100.88B 4.46B 2025-12
Takeda JPY 7.64T 774.9B 2025-12
Vanda Pharmaceuticals USD 243M 136M 2023-12


Minerva Neurosciences Capitalisation Boursière - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.